Karen Jagoda’s Post

#transcript James McCullough, CEO of Renalytix, is focused on preventive care for those most likely to get chronic kidney disease. Diagnostics and risk assessment of patients earlier in the disease cycle emphasize maintaining kidney health rather than managing complications from late-stage kidney disease and kidney failure. Using a machine-learning algorithm to look at blood-based biomarkers and EMR data, the KidneyIntelX system provides the clinician with a risk score and guidelines for treatment. @Renalytix #KidneyDisease #KidneyHealth #DIgitalHealth #AI #MachineLearning #Diagnostics  renalytix.com https://lnkd.in/gb4jWTyz

Risk Assessment Tool Identifies Patients Most Likely to Experience Kidney Disease Progression with James McCullough Renalytix TRANSCRIPT

Risk Assessment Tool Identifies Patients Most Likely to Experience Kidney Disease Progression with James McCullough Renalytix TRANSCRIPT

empoweredpatientradio.com

To view or add a comment, sign in

Explore topics